EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Editorial: HDL and cardiovascular disease: mechanisms, clinical relevance, and therapeutic impacts

Jiayou Wang, Yanqiao Zhang

Frontiers in Cardiovascular Medicine · 26.06.2026 · 13

DOI: 10.3389/fcvm.2026.1910207 ↗

Kurz gefasst

Editorial in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 26.06.2026. Verfasst von Jiayou Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and The Translational Cardiovascular Research Center, University of Arizona College of Medicine - Phoenix, Phoenix, A…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

HDLbiomarkerscardiovascular diseaserisk predictiontherapeutic implication

Autor:innen und Institutionen

  • Department of Internal Medicine and The Translational Cardiovascular Research Center, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, United States.

Zitieren

APA

Wang, J., & Zhang, Y. (2026). Editorial: HDL and cardiovascular disease: mechanisms, clinical relevance, and therapeutic impacts. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1910207

Vancouver

Wang J, Zhang Y. Editorial: HDL and cardiovascular disease: mechanisms, clinical relevance, and therapeutic impacts. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1910207

BibTeX
@article{Wang2026,
  author = {Wang, Jiayou and Zhang, Yanqiao},
  title = {Editorial: HDL and cardiovascular disease: mechanisms, clinical relevance, and therapeutic impacts},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1910207}
}
Kostenlos starten →